Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for bronchoscopy ventilation
ChiCTR2200066502Phase 4Recruiting
- Sponsor
- Suzhou Dushu Lake Hospital
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in bronchopulmonary diseases comparing Remimazolam group with Propofol group (2 arms). Primary endpoints: Tidal impedance variation, ΔEELI (Δ end-expiratory lung impedance) and 1 more. Started Dec 2022; status: recruiting.
02
Drugs
remimazolampropofol
03
Conditions
bronchopulmonary diseases
Beyond the preview
Go deeper on ChiCTR2200066502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066502.